Literature DB >> 8355021

Human parvovirus B19 infections: routine diagnosis by a new nested polymerase chain reaction assay.

P Cassinotti1, M Weitz, G Siegl.   

Abstract

A nested primer PCR assay was developed to detect human parvovirus B19 in various clinical specimens in a routine diagnostic laboratory. Under optimized conditions the highly specific assay had a sensitivity of less than 10 genome units. For practical reasons, however, this sensitivity was adjusted to 10-100 virus genomes in diagnostic applications. Using clinical specimens from 200 patients with suspected B19 infection, nested PCR was shown to have important diagnostic advantages over the detection of B19 specific antibodies. The data suggest that on the basis of serological data as obtained with currently available test systems a considerable proportion of B19 infections would be misdiagnosed. Examples for the usefulness of the PCR assay in routine diagnosis are given.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8355021     DOI: 10.1002/jmv.1890400311

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

Review 1.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

2.  Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops.

Authors:  M Zerbini; M Musiani; G Gentilomi; S Venturoli; G Gallinella; R Morandi
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Dot immunoperoxidase assay for detection of parvovirus B19 antigens in serum samples.

Authors:  G Gentilomi; M Musiani; M Zerbini; G Gallinella; S Venturoli; E Manaresi
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

4.  Detection of parvovirus B19 DNA in bone marrow cells by chemiluminescence in situ hybridization.

Authors:  M Musiani; A Roda; M Zerbini; G Gentilomi; P Pasini; G Gallinella; S Venturoli
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

5.  Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy.

Authors:  Sung-Hsin Kuo; Liang-In Lin; Chee-Jen Chang; Yun-Ru Liu; Kuo-Sin Lin; Ann-Lii Cheng
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient.

Authors:  P Cassinotti; D Schultze; P Schlageter; S Chevili; G Siegl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-09       Impact factor: 3.267

7.  Detection of human parvovirus B19 DNA PCR products by RNA probe hybridization enzyme immunoassay.

Authors:  D D Erdman; E L Durigon; B P Holloway
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

8.  Prenatal diagnosis of parvovirus B19-induced hydrops fetalis by chemiluminescence in situ hybridization.

Authors:  M Musiani; P Pasini; M Zerbini; G Gentilomi; A Roda; G Gallinella; E Manaresi; S Venturoli
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

9.  A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression.

Authors:  S Moffatt; N Tanaka; K Tada; M Nose; M Nakamura; O Muraoka; T Hirano; K Sugamura
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

10.  Parvovirus B19 infection and severe anaemia in Kenyan children: a retrospective case control study.

Authors:  James Wildig; Yvonne Cossart; Norbert Peshu; Nimmo Gicheru; James Tuju; Thomas N Williams; Charles R Newton
Journal:  BMC Infect Dis       Date:  2010-04-03       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.